Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Approval of Upadacitinib in Pediatric Patients with Active Polyarticular Juvenile Idiopathic Arthritis or Active Psoriatic Arthritis: A Regulatory Perspective.
Journal: Journal of clinical pharmacology
Published: May 14, 2025
Population pharmacokinetics of letermovir following oral and intravenous administration in healthy participants and allogeneic hematopoietic cell transplantation recipients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 29, 2020
In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products.
Journal: Therapeutic innovation & regulatory science
Published: October 05, 2019
In Vitro Skin Permeation Methodology for Over-The-Counter Topical Dermatologic Products.
Journal: Therapeutic innovation & regulatory science
Published: June 18, 2019
Pulmonary manifestations of large, medium, and variable vessel vasculitis.
Journal: Respiratory medicine
Published: April 17, 2018
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.
Journal: British journal of cancer
Published: March 03, 2017
Randomized phase 2 study of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus erlotinib in patients with non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 02, 2013
Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer.
Journal: Clinical breast cancer
Published: June 21, 2013
A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhibitor, administered weekly in subjects with advanced malignancies.
Journal: Journal of translational medicine
Published: March 27, 2013
Effect of aprepitant on the pharmacokinetics of the cyclin-dependent kinase inhibitor dinaciclib in patients with advanced malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: July 19, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026